← European Medicine Shortage Tracker · all medicines

Famotidina shortage — availability across Europe

Famotidina currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: FAMOTIDINA · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Famotidina, covering 1 affected product presentation. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
FAMOTIDINA EG
2026-11-01Cessata commercializzazione definitiva
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

Full report history (1 register entry)

Every individual register entry for Famotidina in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITFAMOTIDINA EGShortage2026-11-01Cessata commercializzazione definitiva

Frequently asked

Is Famotidina currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Famotidina?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Famotidina availability data come from?

Directly from the official medicines-agency register that lists Famotidina: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Famotidina — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/famotidina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Famotidina availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/famotidina/">Famotidina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Famotidina: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.